Philippines Pharmaceuticals & Healthcare Q4 2019

Philippines Pharmaceuticals & Healthcare Q4 2019

Key View:

The pharmaceutical industry in the Philippines opposes price controls since profitability will be reduced. Pharmaceuticalcompanies are also seeking taxation relief from the government. Over the longer term, with higher volume sales and greatercompetition in the market, these price controls could be positive for the market. Greater political certainty will facilitate introductionof the changes, but implementation will be hindered by a slowing economy.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
Philippines Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
GlaxoSmithKline
Novartis
Philippines Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook